PSMA1 and neoplasm: At the dose of 1910 nmol/kg, PSMA-1-VcMMAE showed the ability to successfully inhibit C4-2 tumor growth with no weight loss and prolonged animal survival significantly (p = 0.0018) (Figure S9) with a 40% cure rate.